Shanghai Hile Bio-Technology Co., Ltd.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CNE1000022T4
CNY
3.17
0.15 (4.97%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Comparison

Company
Score
Quality
Valuation
Financial
Technical
Shanghai Hile Bio-Technology Co., Ltd.

Why is Shanghai Hile Bio-Technology Co., Ltd. ?

1
  • PRE-TAX PROFIT(Q) At CNY 6.12 MM has Fallen at -89.46%
  • INVENTORY TURNOVER RATIO(HY) Lowest at 0.91 times
  • NET SALES(Q) Lowest at CNY 39.97 MM
2
Consistent Underperformance against the benchmark over the last 3 years
  • Along with generating -33.85% returns in the last 1 year, the stock has also underperformed China Shanghai Composite in each of the last 3 annual periods
stock-recommendationReal-Time Research Report

Verdict Report

How much should you sell?

  1. All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Shanghai Hile Bio-Technology Co., Ltd. for you?

Medium Risk, Low Return

Absolute
Risk Adjusted
Volatility
Shanghai Hile Bio-Technology Co., Ltd.
-57.34%
-0.94
34.13%
China Shanghai Composite
23.91%
1.58
14.20%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor
Value
Sales Growth (5y)
-10.64%
EBIT Growth (5y)
27.57%
EBIT to Interest (avg)
1.32
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.30
Sales to Capital Employed (avg)
0.17
Tax Ratio
13.73%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
1.79%
ROE (avg)
6.32%
stock-recommendationValuation

Valuation Scorecard stock-summary

stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary

Factor
Value
P/E Ratio
6
Industry P/E
Price to Book Value
2.42
EV to EBIT
53.22
EV to EBITDA
37.14
EV to Capital Employed
3.17
EV to Sales
10.61
PEG Ratio
0.12
Dividend Yield
2.36%
ROCE (Latest)
5.96%
ROE (Latest)
37.48%
stock-recommendationTechnicals

Technical key factors

Indicator
Weekly
Monthly
MACD
Bearish
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Bearish
Dow Theory
No Trend
Bearish
OBV
No Trend
Mildly Bearish
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend

Financial Trend Scorecard stock-summary

stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

8What is working for the Company
NET PROFIT(HY)

Higher at CNY 310.79 MM

DEBT-EQUITY RATIO (HY)

Lowest at -33.48 %

-19What is not working for the Company
NET SALES(HY)

At CNY 85.52 MM has Grown at -45.29%

PRE-TAX PROFIT(Q)

At CNY 9.17 MM has Fallen at -91.83%

NET PROFIT(Q)

At CNY 6.35 MM has Fallen at -92.12%

ROCE(HY)

Lowest at -25.66%

RAW MATERIAL COST(Y)

Grown by 8.94% (YoY

OPERATING PROFIT(Q)

Lowest at CNY 7.32 MM

OPERATING PROFIT MARGIN(Q)

Lowest at 15.44 %

Here's what is working for Shanghai Hile Bio-Technology Co., Ltd.

Debt-Equity Ratio
Lowest at -33.48 %
in the last five Semi-Annual periods
MOJO Watch
The company has been reducing its borrowing as compared to equity capital

Debt-Equity Ratio

Here's what is not working for Shanghai Hile Bio-Technology Co., Ltd.

Net Sales
At CNY 85.52 MM has Grown at -45.29%
Year on Year (YoY)
MOJO Watch
Near term sales trend is very negative

Net Sales (CNY MM)

Pre-Tax Profit
At CNY 9.17 MM has Fallen at -91.83%
over average net sales of the previous four periods of CNY 112.17 MM
MOJO Watch
Near term Pre-Tax Profit trend is very negative

Pre-Tax Profit (CNY MM)

Net Profit
At CNY 6.35 MM has Fallen at -92.12%
over average net sales of the previous four periods of CNY 80.62 MM
MOJO Watch
Near term Net Profit trend is very negative

Net Profit (CNY MM)

Operating Profit
Lowest at CNY 7.32 MM
in the last five periods
MOJO Watch
Near term Operating Profit trend is negative

Operating Profit (CNY MM)

Operating Profit Margin
Lowest at 15.44 %
in the last five periods
MOJO Watch
Company's profit margin has deteriorated

Operating Profit to Sales

Raw Material Cost
Grown by 8.94% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin

Raw Material Cost as a percentage of Sales

Non Operating Income
Highest at CNY 0.21 MM
in the last five periods
MOJO Watch
Increased income from non business activities may not be sustainable

Non Operating income